Project description
Tissue-regenerating breast implants
Breast cancer affects a significant number of women who undertake mastectomy as part of their treatment. However, only a small proportion receive reconstructive surgery. Funded by the European Innovation Council, the MATTISSE project introduces a novel breast implant made of 3D printed biomaterials. The implant can be adapted to patient breast morphology and can guide the natural regeneration of the breast adipose tissue where needed. The implant is fully degraded in a year, without leaving behind any foreign bodies which often prevents women from having reconstructive breast surgery. Importantly, breast reconstruction is achieved with a single surgical operation.
Objective
LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery. MATTISSE technology uses a Tissue Engineering Chamber implanted in the former breast and made of 3D printed biocompatible and bioabsorbable polymer. MATTISSE regenerates autologous adipose tissue within 3-6 months, women recover a full breast in 18 months with a fully degraded implant at an affordable price and free from numerous surgical procedures. There is no longer any risk related to silicone implants thanks to the complete recovery with natural tissue.
After validating the effectiveness of the MATTISSE medical device on animal models, this project aims at performing the mandatory clinical studies to launch the product on the EU market with the CE mark. A commercial team will be recruited to define and implement a marketing plan to ensure the success of MATTISSE. Lattice Medical plans to support 40000 women by 2030.
Fields of science
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
59120 LOOS
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.